Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Long-Term Investments: 2010-2020

Historic Long-Term Investments for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2020 value amounting to $227.1 million.

  • Neurocrine Biosciences' Long-Term Investments rose 183.19% to $513.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $513.7 million, marking a year-over-year increase of 183.19%. This contributed to the annual value of $227.1 million for FY2020, which is 24.22% down from last year.
  • Neurocrine Biosciences' Long-Term Investments amounted to $227.1 million in FY2020, which was down 24.22% from $299.7 million recorded in FY2019.
  • Neurocrine Biosciences' 5-year Long-Term Investments high stood at $299.7 million for FY2019, and its period low was $43.5 million during FY2016.
  • In the last 3 years, Neurocrine Biosciences' Long-Term Investments had a median value of $227.1 million in 2020 and averaged $247.6 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Long-Term Investments crashed by 47.28% in 2016, and later skyrocketed by 468.78% in 2017.
  • Over the past 5 years, Neurocrine Biosciences' Long-Term Investments (Yearly) stood at $43.5 million in 2016, then soared by 468.78% to $247.4 million in 2017, then decreased by 12.67% to $216.0 million in 2018, then soared by 38.73% to $299.7 million in 2019, then fell by 24.22% to $227.1 million in 2020.